Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1968 Nov 23;4(5629):479–482. doi: 10.1136/bmj.4.5629.479

Significance of Rh-sensitization during Pregnancy: Its Relation to a Preventive Programme

John C Godel, Donald I Buchanan, Jean M Jarosch, Maureen McHugh
PMCID: PMC1912706  PMID: 4177135

Abstract

A study of the incidence of Rh-sensitization showed a 6.5% incidence of anti-D appearing for the first time during the last trimester of pregnancy. In 24 of the 29 subjects these antibodies were weak, and were found only when a sensitive technique using enzyme-treated Rh-deletion test cells was employed. The remaining five, however, had high-titre antibodies, which were associated with a positive Coombs test on cord blood.

Rh-immune globulin administered at delivery resulted in disappearance of the anti-D in all but one of the subjects with weak antibody to whom it was given, suggesting that this treatment can reverse early sensitization. There was no effect when Rh-immune globulin was given to one subject with a high anti-D titre.

Since sensitization has been found to occur frequently during the last trimester of pregnancy, an antenatal schedule of prophylaxis is advocated.

Full text

PDF
479

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BUCHANAN D. I. Blood genotypes-D-/-D- and Cde/-D-; transfusion therapy and some effects of multiple pregnancy. Am J Clin Pathol. 1956 Jan;26(1):21–28. doi: 10.1093/ajcp/26.1.21. [DOI] [PubMed] [Google Scholar]
  2. BUCHANAN D. I., DIERICH K. P. THE USE OF A PROTEOLYTIC ENZYME OF STREPTOMYCES GRISEUS (PROTEASE G) IN BLOOD BANKING: A PRELIMINARY ACCOUNT. Transfusion. 1965 Jan-Feb;5:11–16. doi: 10.1111/j.1537-2995.1965.tb01130.x. [DOI] [PubMed] [Google Scholar]
  3. COHEN F., ZUELZER W. W. IDENTIFICATION OF BLOOD GROUP ANTIGENS BY IMMUNOFLUORESCENCE AND ITS APPLICATION TO THE DETECTION OF THE TRANSPLACENTAL PASSAGE OF ERYTHROCYTES IN MOTHER AND CHILD. Vox Sang. 1964 Jan-Feb;9:75–78. doi: 10.1111/j.1423-0410.1964.tb03773.x. [DOI] [PubMed] [Google Scholar]
  4. FINKELSTEIN M. S., UHR J. W. SPECIFIC INHIBITION OF ANTIBODY FORMATION BY PASSIVELY ADMINISTERED 19S AND 7S ANTIBODY. Science. 1964 Oct 2;146(3640):67–69. doi: 10.1126/science.146.3640.67. [DOI] [PubMed] [Google Scholar]
  5. Freda V. J., Gorman J. G., Pollack W. Rh factor: prevention of isoimmunization and clinical trial on mothers. Science. 1966 Feb 18;151(3712):828–830. doi: 10.1126/science.151.3712.828. [DOI] [PubMed] [Google Scholar]
  6. Mollison P. L. Suppression of Rh-immunization by passively administered anti-Rh. Br J Haematol. 1968 Jan;14(1):1–4. doi: 10.1111/j.1365-2141.1968.tb01466.x. [DOI] [PubMed] [Google Scholar]
  7. Wigzell H. Antibody synthesis at the cellular level. Antibody-induced suppression of 7S antibody synthesis. J Exp Med. 1966 Nov 1;124(5):953–969. doi: 10.1084/jem.124.5.953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. ZIPURSKY A., POLLOCK J., NEELANDS P., CHOWN B., ISRAELS L. G. THE TRANSPLACENTAL PASSAGE OF FOETAL RED BLOOD-CELLS AND THE PATHOGENESIS OF RH IMMUNISATION DURING PREGNANCY. Lancet. 1963 Sep 7;2(7306):489–493. doi: 10.1016/s0140-6736(63)90228-9. [DOI] [PubMed] [Google Scholar]
  9. Zipursky A., Israels L. G. The pathogenesis and prevention of Rh immunization. Can Med Assoc J. 1967 Nov 18;97(21):1245–1257. [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES